Cognition Therapeutics Inc
CGTXAs of the close on Sep 25, 2026
Price
$0.94
Market cap
—
No recent share count on file
P/E (diluted TTM)
—
The fourth quarter's per-share figure could not be confirmed from the annual report
EPS (TTM)
—
The fourth quarter's per-share figure could not be confirmed from the annual report
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Cognition Therapeutics Inc Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 5 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 22, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| JONES FINANCIAL COMPANIES LLLP | 2026-03-31 | 35,481 | $25.9K | SEC filing |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 2026-03-31 | 17,467 | $13.3K | SEC filing |
| MERCER GLOBAL ADVISORS INC /ADV | 2026-03-31 | 15,951 | $12.1K | SEC filing |
| FCA CORP /TX | 2026-03-31 | 52,536 | $39.9K | SEC filing |
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Management | 2026-03-31 | 48,000 | $36.5K | SEC filing |
| Creative Planning | 2026-03-31 | 30,204 | $22.9K | SEC filing |
| Schonfeld Strategic Advisors LLC | 2026-03-31 | 10,000 | $7.59K | SEC filing |
| BIOS Capital Management, LP | 2026-03-31 | 6,000,000 | $4.56M | SEC filing |
| CITIZENS FINANCIAL GROUP INC/RI | 2026-03-31 | 13,679 | $10.4K | SEC filing |
| Versant Capital Management, Inc | 2026-03-31 | 3,073 | $2.33K | SEC filing |
| PRIVATE MANAGEMENT GROUP INC | 2026-03-31 | 24,000 | $18.2K | SEC filing |
| GAMCO INVESTORS, INC. ET AL | 2026-03-31 | 20,000 | $15.2K | SEC filing |
| CWA Asset Management Group, LLC | 2026-03-31 | 25,250 | $19.2K | SEC filing |
| NORTHERN TRUST CORP | 2026-03-31 | 168,686 | $128K | SEC filing |
| RAYMOND JAMES FINANCIAL INC | 2026-03-31 | 47,500 | $36.1K | SEC filing |
| Focus Partners Wealth | 2026-03-31 | 15,000 | $11.4K | SEC filing |
| Robertson Stephens Wealth Management, LLC | 2026-03-31 | 10,000 | $7.6K | SEC filing |
| FIFTH THIRD BANCORP | 2026-03-31 | 5,000 | $3.8K | SEC filing |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 2026-03-31 | 195,000 | $148K | SEC filing |
| Caitong International Asset Management Co., Ltd | 2026-03-31 | 1 | Not shown | SEC filing |
- Each value is checked against Cognition Therapeutics Inc's share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 1 row: the value per share could not be confirmed against the share prices on file from within three months of the report date.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- WELLS FARGO & COMPANY/MN: 3,000 shares reported 2025-12-31; 3,050 shares reported 2026-03-31.
- RENAISSANCE TECHNOLOGIES LLC: 969,513 shares reported 2025-12-31; 1,117,136 shares reported 2026-03-31.
- Barry Investment Advisors, LLC: 10,000 shares reported 2025-12-31; 10,000 shares reported 2026-03-31.
- CITADEL ADVISORS LLC: 161,201 shares reported 2025-12-31; 25,905 shares reported 2026-03-31.
- Bryn Mawr Trust Advisors, LLC: 29,050 shares reported 2025-12-31; 29,050 shares reported 2026-03-31.
- Chescapmanager LLC: 997,029 shares reported 2025-12-31; 997,029 shares reported 2026-03-31.
- BRADLEY FOSTER & SARGENT INC/CT: 11,722 shares reported 2025-12-31; 11,722 shares reported 2026-03-31.
- STATE STREET CORP: 314,483 shares reported 2025-12-31; 314,483 shares reported 2026-03-31.
- Virtu Financial LLC: 39,988 shares reported 2025-12-31; 70,162 shares reported 2026-03-31.
- Retirement Planning Group, LLC: 10,000 shares reported 2025-12-31; 10,000 shares reported 2026-03-31.
- Rockefeller Capital Management L.P.: 19,231 shares reported 2025-12-31; 19,231 shares reported 2026-03-31.
- CM Management, LLC: 200,000 shares reported 2025-12-31; 400,000 shares reported 2026-03-31.
Showing the 12 most recent filer reports.
41 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Cognition Therapeutics Inc's recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2022-11-15 · Fletcher Aaron G.L.: Larger than 31 of the 34 other insider purchases of Common Stock on file. SEC filing
- 2022-11-15 · Kreis Leslie W.: Larger than 31 of the 34 other insider purchases of Common Stock on file. SEC filing
- 2022-11-15 · Fletcher Aaron G.L.: Larger than 33 of the 34 other insider purchases of Common Stock on file. SEC filing
- 2022-11-15 · Kreis Leslie W.: Larger than 33 of the 34 other insider purchases of Common Stock on file. SEC filing
Independent insiders buying near the same time
- 2026-04-16–2026-04-16: 3 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
- 2022-11-28–2022-11-29: 7 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing , filing )
- 2022-11-15–2022-11-16: 14 event(s) across 4 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing , filing )
- 2021-10-13–2021-10-13: 9 event(s) across 5 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing , filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-04-16 | Ricciardi Lisa · CEO & President | Common Stock | P — Open market or private purchase | +9,175 | 1.10 | SEC filing |
| 2026-04-16 | Doyle John Brendan · Chief Financial Officer | Common Stock | P — Open market or private purchase | +10,000 | 1.13 | SEC filing |
| 2026-04-16 | Caggiano Anthony · Chief Medical Officer | Common Stock | P — Open market or private purchase | +10,000 | 1.11 | SEC filing |
| 2025-01-31 | Ricciardi Lisa · CEO & President | Common Stock | P — Open market or private purchase | +38,851 | 0.77 | SEC filing |
| 2024-03-14 | Ricciardi Lisa · CEO & President | Common Stock | P — Open market or private purchase | +5,700 | 1.75 | SEC filing |
| 2022-11-29 | RICHSTONE ELLEN B · Director | Common Stock | P — Open market or private purchase | +10,000 | 2.66 | SEC filing |
| 2022-11-28 | BIOS Memory SPV II, LP · Director, 10% owner | Common Stock | P — Open market or private purchase | +1,871 | 2.65 | SEC filing |
| 2022-11-28 | BIOS Memory SPV II, LP · Director, 10% owner | Common Stock | P — Open market or private purchase | +12,220 | 2.65 | SEC filing |
Showing 8 of 15 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-17 | Monia Brett P · Director | Common Stock | A — Grant, award, or other acquisition | +25,000 | SEC filing |
| 2026-06-17 | RICHSTONE ELLEN B · Director | Common Stock | A — Grant, award, or other acquisition | +25,000 | SEC filing |
| 2026-06-17 | BIOS Memory SPV I, LP · Director, 10% owner | Common Stock | A — Grant, award, or other acquisition | +25,000 | SEC filing |
| 2026-06-17 | Wallace Peggy · Director | Common Stock | A — Grant, award, or other acquisition | +25,000 | SEC filing |
| 2026-06-17 | Khattar Jack A. · Director | Common Stock | A — Grant, award, or other acquisition | +25,000 | SEC filing |
| 2026-05-01 | Doyle John Brendan · Chief Financial Officer | Common Stock | F — Payment of exercise price or tax by delivering securities | −8,567 | SEC filing |
| 2026-02-15 | Caggiano Anthony · Chief Medical Officer | Common Stock | F — Payment of exercise price or tax by delivering securities | −4,680 | SEC filing |
| 2026-02-15 | Doyle John Brendan · Chief Financial Officer | Common Stock | F — Payment of exercise price or tax by delivering securities | −1,560 | SEC filing |
Showing 8 of 30 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2022-09-27 | Golden Seeds Cognition Therapeutics LLC · 10% owner | Common Stock | J — Other acquisition or disposition | −2,489,682 | SEC filing |
| 2022-09-27 | Wallace Peggy · Director | Common Stock | J — Other acquisition or disposition | +22,461 | SEC filing |
| 2022-06-10 (amended) | Fletcher Aaron G.L. · Director, 10% owner | Stock Option (right to buy) | J — Other acquisition or disposition | −2,469 | SEC filing |
| 2022-06-10 (amended) | Fletcher Aaron G.L. · Director, 10% owner | Stock Option (right to buy) | J — Other acquisition or disposition | +2,469 | SEC filing |
| 2022-06-10 (amended) | Fletcher Aaron G.L. · Director, 10% owner | Stock Option (right to buy) | J — Other acquisition or disposition | +8,335 | SEC filing |
| 2022-01-31 | Fletcher Aaron G.L. · Director, 10% owner | Stock Option (right to buy) | J — Other acquisition or disposition | +1,145 | SEC filing |
| 2022-01-31 | Fletcher Aaron G.L. · Director, 10% owner | Stock Option (right to buy) | J — Other acquisition or disposition | −1,145 | SEC filing |
Showing 7 of 7 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.